Notice of General Meeting
CRISM Therapeutics Corporation has announced a General Meeting to be held on Monday, June 15, 2026, at 10:00 a.m. This meeting follows the Company's Fundraising announcement on May 26, 2026, and further details will be posted to shareholders. The company is a UK clinical-stage drug delivery firm focused on localized and sustained chemotherapy delivery for solid tumors, with its lead product, ChemoSeed, designed for direct implantation into tumors or resection margins.
Select text to share a quote on X · sign in to keep highlights & notes in your CRTX notes
CRISM Therapeutics Corporation (AIM: CRTX), a UK clinical-stage drug delivery company focused on the localised and sustained delivery of chemotherapy drugs, announces that, following the Company's Fundraising announcement of 26 May 2026, the General Meeting will take place at 10.00 a.m. on Monday 15 June 2026 at the offices of Fieldfisher LLP, Riverbank House, 2 Swan Lane, London, EC4R 3TT. Further details are set out in the Notice of General Meeting, which will be posted to Shareholders today.
A copy of the Notice of General Meeting will shortly be available on the Company's website at: https://www.crismtherapeutics.com/investors/documents-circulars/
Capitalised terms not defined shall have the same meaning as given to them in the Company's announcement of 26 May 2026.
The Company's LEI is 213800XFW6MKVCHHPW88.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.